|
MIND-BODY THERAPIES FOR PATIENTS WITH END-STAGE RENAL DISEASE |
5K23AT006965-06 |
BIRDEE, GURJEET SINGH |
NCCIH |
2016 |
|
MINDFULNESS-BASED STRESS REDUCTION FOR MULTIPLE SCLEROSIS: FEASIBILITY, DURABILITY, AND CLINICAL OUTCOMES |
5K23AT008211-02 |
SENDERS, ANGELA |
NCCIH |
2016 |
|
MECHANISMS OF HUMAN IMMUNE MODULATION BY ORAL N-ACETYLGLUCOSAMINE |
5R01AT007452-03 |
DEMETRIOU, MICHAEL |
NCCIH |
2016 |
|
NOVEL SYNTHETIC SDG TO TREAT TRAUMA-INDUCED INFLAMMATION |
5R21AT008291-02 |
CHRISTOFIDOU-SOLOMIDOU, MELPO |
NCCIH |
2016 |
|
OSTEOGENIC EFFECTS OF DIETARY ANTHOCYANINS IN TRANSGENIC MEDAKA |
5R21AT008452-02 |
MAHADY, GAIL B |
NCCIH |
2016 |
|
COLLABORATIVE CARE FOR VETERANS WITH SPINE PAIN AND MENTAL HEALTH CONDITIONS |
5R34AT008427-03 |
LONG, CYNTHIA R |
NCCIH |
2016 |
|
NONINVASIVE BRAIN STIMULATION FOR PAIN SUPPRESSION |
5R44AT008637-02 |
WAGNER, TIMOTHY ANDREW |
NCCIH |
2016 |
|
AIR POLLUTION, GESTATIONAL DIABETES, AND AUTISM SPECTRUM DISORDER |
1F31ES027340-01 |
JO, HEEJOO |
NIEHS |
2016 |
|
THE SYNAPTIC BASIS OF MOTOR IMPAIRMENT FOLLOWING EARLY DEVELOPMENTAL MANGANESE EXPOSURE |
1F32ES026872-01 |
MOYER, CAITLIN ELIZABETH |
NIEHS |
2016 |
|
ROLE OF MITOCHONDRIAL CYP2E1 IN CHEMICAL EXPOSURE-DRIVEN NEURODEGENERATION |
1F32ES027306-01 |
HARTMAN, JESSICA HELENE |
NIEHS |
2016 |